ASX:PMEHealthcare Services
A Look At Pro Medicus’s Valuation As US Hospital Contracts And AI Imaging Draw Attention
Why Pro Medicus is back in focus
Recent media coverage around Pro Medicus (ASX:PME) has zeroed in on its premium radiology imaging software, long term US hospital contracts, and use of AI, while investor attention is also focused on its premium pricing.
See our latest analysis for Pro Medicus.
Despite the recent excitement around its US contracts and AI capabilities, Pro Medicus has been in a technical downtrend, with a 30 day share price return of a 19.83% decline and a 1 year total...